Marimed (MRMD) Capital Leases (2019 - 2026)

Marimed (MRMD) has 8 years of Capital Leases data on file, last reported at $1.6 million in Q1 2026.

• On a quarterly basis, Capital Leases fell 18.05% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 18.05% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, up 1.56% from the prior year.
• Capital Leases for Q1 2026 stood at $1.6 million, down from $2.0 million in the prior quarter.
• Over the last five years, Capital Leases for MRMD reached as high as $2.7 million in Q2 2024 and fell as low as $338000.0 in Q2 2022.
• Historically, Capital Leases has averaged $1.6 million across 5 years, with a median of $1.9 million in 2025.
• Across the five-year window, Capital Leases soared 1995.45% in 2022 and dropped 18.05% in 2026, its largest moves.
• Year by year, Capital Leases stood at $461000.0 in 2022, then soared by 364.21% to $2.1 million in 2023, then retreated by 10.0% to $1.9 million in 2024, then climbed by 1.56% to $2.0 million in 2025, then fell by 19.94% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Capital Leases figures were $1.6 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.